Samman, W.A.; Selim, S.M.; El Fayoumi, H.M.; El-Sayed, N.M.; Mehanna, E.T.; Hazem, R.M.
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. Pharmaceuticals 2023, 16, 753.
https://doi.org/10.3390/ph16050753
AMA Style
Samman WA, Selim SM, El Fayoumi HM, El-Sayed NM, Mehanna ET, Hazem RM.
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. Pharmaceuticals. 2023; 16(5):753.
https://doi.org/10.3390/ph16050753
Chicago/Turabian Style
Samman, Waad A., Salma M. Selim, Hassan M. El Fayoumi, Norhan M. El-Sayed, Eman T. Mehanna, and Reem M. Hazem.
2023. "Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism" Pharmaceuticals 16, no. 5: 753.
https://doi.org/10.3390/ph16050753
APA Style
Samman, W. A., Selim, S. M., El Fayoumi, H. M., El-Sayed, N. M., Mehanna, E. T., & Hazem, R. M.
(2023). Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism. Pharmaceuticals, 16(5), 753.
https://doi.org/10.3390/ph16050753
